Beyond Air (XAIR) Receivables - Other (2016 - 2022)
Beyond Air recorded quarterly Receivables - Other of $1.1 million in Q4 2022, little changed quarter-over-quarter from $1.1 million in Q4 2021, and little changed year-over-year from $1.1 million in Q4 2021.
Beyond Air's Receivables - Other history runs 4 years deep, the most recent figure standing at $1.1 million for Q4 2022.
- In Q4 2022, Receivables - Other changed 0.0% year-over-year to $1.1 million; the TTM figure through Dec 2022 stood at $1.1 million (changed 0.0% YoY), while the FY2017 annual figure was $63000.0, down 19.23% from the prior year.
- Receivables - Other came in at $1.1 million for Q4 2022 at Beyond Air, roughly flat from $1.1 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $1.1 million in Q4 2021 to a low of $1.1 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.10 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Dec 31, 2017 | 63,000.00 |
| Dec 31, 2017 | 63,000.00 |
| Dec 31, 2016 | 78,000.00 |
| Dec 31, 2016 | 78,000.00 |